|

Mid-day market update: LiveRamp surges following Q4 results; Syndax Pharmaceuticals shares plummet

Midway through trading Friday, the Dow traded down 0.56% to 24338.21 while the NASDAQ fell 0.19% to 9266.93. The S&P also fell, dropping 0.33% to 2938.92.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 1,577,750 cases with around 94,720 deaths. Brazil confirmed a total of over 310,080 COVID-19 cases with 20,040 deaths, while Russia reported a total of at least 326,440 confirmed cases and 3,240 deaths. In total, there were at least 5,125,610 cases of COVID-19 worldwide with over 333,380 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Real estate shares climbed 1.3% on Friday. Meanwhile, top gainers in the sector included Altisource Portfolio Solutions S.A. ASPS 14.23%, up 9%, and American Tower Corporation AMT 5.26%, up 5%.

In trading on Friday, energy shares dipped 1.4%.

Top Headline

Alibaba Group Holding Ltd - ADR BABA 5.25% reported better-than-expected results for its fourth quarter.

Alibaba reported quarterly earnings of $1.30 per share on Friday, which beat the analyst consensus estimate of 87 cents. The company reported quarterly sales of $16.144 billion, which beat the analyst consensus estimate of $15.200 billion. Domestic same-store sales slipped 5.7% during the quarter.

Equities Trading UP

LiveRamp Holdings, Inc. RAMP 24.25% shares shot up 21% to $47.03 after reporting upbeat Q4 results.

Shares of Tetraphase Pharmaceuticals, Inc. TTPH 14.35% got a boost, shooting 24% to $2.86. Tetraphase Pharmaceuticals, which has been pursued by multiple companies, said its board has determined that the latest proposal from Melinta Therapeutics, Inc. is a "Superior Offer." Melinta has offered $27 million in cash, plus an additional $12.5 million in cash potentially payable under contingent value rights to be issued in the proposed acquisition.

Navidea Biopharmaceuticals, Inc. NAVB 86.74% shares were also up, gaining 85% to $2.3499 after the company announced positive preliminary results from the second interim analysis of its ongoing NAV3-31 Phase 2B study.

Equities Trading DOWN

Recon Technology, Ltd. RCON 45.14% shares tumbled 45% to $2.05 after the company reported pricing of approximately $2.1 million registered direct offering.

Shares of Geron Corporation GERN 8.42% were down 17% to $1.635 after the company reported pricing of public offering of common stock and warrants.

Syndax Pharmaceuticals, Inc. SNDX 24.15% was down, falling 23% to $15.72 after the company said a late-stage study that evaluated its investigational compound entinostat along with exemestane in patients with HR+, HER2- breast cancer who have progressed on a non-steroidal aromatase inhibitor did not achieve the primary endpoint of demonstrating a statistically significant overall survival benefit over hormone therapy alone.

Commodities

In commodity news, oil traded down 3.7% to $32.67, while gold traded up 0.8% to $1,736.40.

Silver traded up 2% Friday to $17.71, while copper fell 2.1% to $2.38.

Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 slipped 0.01%, the Spanish Ibex Index rose 0.23%, while Italy’s FTSE MIB Index rose 1.22%. Meanwhile, the German DAX gained 0.11%, and the French CAC 40 rose 0.18% while UK shares fell 0.25%.

Economics

The Baker Hughes North American rig count report for the recent week will be released at 1:00 p.m. ET.

Author

Benzinga Team

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

More from Benzinga Team
Share:

Editor's Picks

EUR/USD retreats toward 1.1600 after upbeat US data

EUR/USD pulls away from session highs and declines toward 1.1600 in the American session on Wednesday. Upbeat private sector employment and ISM Services PMI data from the US help the US Dollar (USD) stay resilient against its rivals, limiting the pair's upside.

GBP/USD meets resistance around 1.3400

In line with its risk-linked peers, GBP/USD stages a modest comeback on Wednesday, although meeting some resistance around the 1.3400 neighbourhood. Cable’s humble recovery struggles to gather momentum as the Greenback benefits from better-than-forecast macroeconomic data releases.

Gold loses traction after testing $5,200

Gold corrects lower after testing $5,200 but manages to stay in positive territory in the second hald of the day on Wednesday. The precious metal remains well supported by the deterioration of the geopolitical scenario in the Middle East, while the US Dollar's resilience caps the upside.

Crypto Today: Bitcoin, Ethereum, XRP rebound amid mixed ETF flows

The cryptocurrency market is showing subtle recovery signs despite heightened global uncertainty following the United States (US) and Israel attacks on Iran and the subsequent retaliations that have morphed into a wider Middle East war.

First Venezuela, now Iran: The US-China energy war escalates

At first glance, the latest escalation involving the United States with both Iran and Venezuela looks like another chapter in a long-running geopolitical story. But viewed through a broader strategic lens, something else may be unfolding: Energy.

Solana Price Forecast: SOL consolidation near resistance as ETF inflows offer mild support

Solana price is facing slight rejection as it approaches the upper boundary of the consolidation range at around $88 on Wednesday. Institutional demand is strengthening as spot Exchange Traded Funds recorded two consecutive inflows so far this week.